Skip to content
healthcare.dev

Bludigo

NDC 25021-840, Indigotindisulfonate Sodium, injection, from Sagent Pharmaceuticals.

Product NDC
25021-840
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-840 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INDIGOTINDISULFONATE SODIUM8 mg/mL

Pharmacologic classes

Diagnostic Dye [EPC]; Dyes [MoA]

Package NDCNDC-11Package
25021-840-05250210840055 AMPULE in 1 CARTON (25021-840-05) / 5 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2b91c39d-5f15-4dcf-9d3d-b378470e6bd7

Use it

Look up 25021-840 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-840 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-840. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.